Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jorgensen

Showing results (481-490 of 567) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|May 2, 2003
Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analoguesMarilyn B Kroeger Smith, Brian M Hose, Arie Hawkins, et al.
The Lancet. Gastroenterology & Hepatology|November 18, 2017
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studiesJames W Dear, Joanna I Clarke, Ben Francis, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 7, 2020
Can risk prediction models help us individualise stillbirth prevention? A systematic review and critical appraisal of published risk modelsR Townsend, A Manji, J Allotey, et al.
Blood|December 11, 2012
The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemiaAthina Giannoudis, Lihui Wang, Andrea L Jorgensen, et al.
NPJ Drug Discovery|September 4, 2025
Mechanistic basis for a novel dual-function Gag-Pol dimerizer potentiating CARD8 inflammasome activation and clearance of HIV-infected cellsKlarissa Hollander, Swapnil C Devarkar, Su Tang, et al.
Neoplasia (New York, N.Y.)|February 10, 2019
Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem CellsRobert C Fisher, Kishan Bellamkonda, L Alex Molina, et al.
Cytometry. Part B, Clinical Cytometry|June 18, 2022
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometryHong Fang, Sa A Wang, Shimin Hu, et al.
European Journal of Endocrinology|February 24, 2016
What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?A Muhammad, A J van der Lely, R D O'Connor, et al.
Pharmacogenetics and Genomics|April 27, 2017
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicitySigne Thiesen, Peng Yin, Andrea L Jorgensen, et al.
Diabetologia|January 15, 2026
Identification of a genetic risk factor for metformin-induced vitamin B<sub>12</sub> deficiencyFaye D Baldwin, Khaled F Bedair, Andrea L Jorgensen, et al.
Pageof 57

Showing results (481-490 of 567) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|May 2, 2003
Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analoguesMarilyn B Kroeger Smith, Brian M Hose, Arie Hawkins, et al.
The Lancet. Gastroenterology & Hepatology|November 18, 2017
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studiesJames W Dear, Joanna I Clarke, Ben Francis, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 7, 2020
Can risk prediction models help us individualise stillbirth prevention? A systematic review and critical appraisal of published risk modelsR Townsend, A Manji, J Allotey, et al.
Blood|December 11, 2012
The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemiaAthina Giannoudis, Lihui Wang, Andrea L Jorgensen, et al.
NPJ Drug Discovery|September 4, 2025
Mechanistic basis for a novel dual-function Gag-Pol dimerizer potentiating CARD8 inflammasome activation and clearance of HIV-infected cellsKlarissa Hollander, Swapnil C Devarkar, Su Tang, et al.
Neoplasia (New York, N.Y.)|February 10, 2019
Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem CellsRobert C Fisher, Kishan Bellamkonda, L Alex Molina, et al.
Cytometry. Part B, Clinical Cytometry|June 18, 2022
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometryHong Fang, Sa A Wang, Shimin Hu, et al.
European Journal of Endocrinology|February 24, 2016
What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?A Muhammad, A J van der Lely, R D O'Connor, et al.
Pharmacogenetics and Genomics|April 27, 2017
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicitySigne Thiesen, Peng Yin, Andrea L Jorgensen, et al.
Diabetologia|January 15, 2026
Identification of a genetic risk factor for metformin-induced vitamin B<sub>12</sub> deficiencyFaye D Baldwin, Khaled F Bedair, Andrea L Jorgensen, et al.
Pageof 57